2013/722/EU: Commission Implementing Decision of 29 November 2013 approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2014 and the following years (notified under document C(2013) 8417)

For the purposes of the present Implementing Decision the following definitions shall apply: (a)sampling of domestic animalsthe procedure of collecting biological material from animals at the holding by or on behalf of the Competent Authority for laboratory testing;(b)sampling of poultry flocksThe collection of samples from the environment of a poultry flock performed by or on behalf of the Competent Authority in the framework of a programme for the control of certain zoonotic Salmonella;(c)testthe procedure performed on a sample in a laboratory to detect, diagnose or evaluate disease agent presence or absence, disease process or the susceptibility to a specific disease agent;(d)tuberculin testingThe procedure of performing a tuberculin skin test as defined in Annex B point 2 to Council Directive 64/432/EEC , in the framework of a bovine tuberculosis programme.

1 The programmes for the eradication of bovine brucellosis submitted by Spain, Croatia, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The financial contribution by the Union: (a) shall be at a rate of 50 % of the unit cost defined in points 1(a) and 4(a) of Annex I for: (i) the sampling of domestic animals; (ii) rose bengal tests; (iii) complement fixation tests; (b) shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for: (i) SAT tests up to a maximum of EUR 0,25 on average per test; (ii) ELISA tests up to a maximum of EUR 0,5 on average per test; (iii) bacteriological tests up to a maximum of EUR 10 on average per test; (iv) purchase of vaccines up to a maximum of EUR 0,50 on average per dose; (v) the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes up to a maximum of EUR 375 on average per animal; (c) and shall not exceed the following: (i) EUR 4900000 for Spain; (ii) EUR 150000 for Croatia; (iii) EUR 2715000 for Italy; (iv) EUR 805000 for Portugal; (v) EUR 1355000 for the United Kingdom.

1 The programmes for the eradication of bovine tuberculosis submitted by Ireland, Spain, Croatia, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The financial contribution by the Union to the Member States referred to in paragraph 1, except for Ireland: (a) shall be at a rate of 50 % of the unit cost defined in points 3 and 4(b) of Annex I for: (i) tuberculin testing; (ii) gamma-interferon tests; (b) shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the cost of: (i) bacteriological tests up to a maximum of EUR 10 on average per test; (ii) the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes up to a maximum of EUR 375 on average per animal; (c) and shall not exceed the following: (i) EUR 11780000 for Spain; (ii) EUR 330000 for Croatia; (iii) EUR 4570000 for Italy; (iv) EUR 1035000 for Portugal; (v) EUR 31000000 for the United Kingdom.

3 The financial contribution by the Union to Ireland: (a) shall be at a rate of 50 % of the unit cost defined in point 4(b) of Annex I for gamma-interferon tests; (b) shall be at a rate of 50 % of the eligible costs to be incurred by Ireland for the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes up to a maximum of EUR 375 on average per animal; (c) shall not exceed EUR 7390000.

1 The programmes for the eradication of ovine and caprine brucellosis submitted by Greece, Spain, Croatia, Italy, Cyprus, and Portugal are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The financial contribution by the Union to the Member States referred to in paragraph 1, except for Greece: (a) shall be at a rate of 50 % of the unit cost defined in points 1(b) and 4(c) of Annex I for: (i) the sampling of domestic animals; (ii) rose bengal tests; (iii) complement fixation tests; (b) shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for: (i) bacteriological tests up to a maximum of EUR 10 on average per test; (ii) the purchase of vaccines up to a maximum of EUR 0,50 on average per dose; (iii) the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes up to a maximum of EUR 50 on average per animal; (c) and shall not exceed the following: (i) EUR 7715000 for Spain; (ii) EUR 385000 for Croatia; (iii) EUR 3925000 for Italy; (iv) EUR 175000 for Cyprus; (v) EUR 1125000 for Portugal.

3 The financial contribution by the Union for Greece: (a) shall be at a rate of 75 % of the unit cost defined in points 4(c) of Annex I for: (i) rose bengal tests; (ii) complement fixation tests; (b) shall be at a rate of 75 % of the eligible costs to be incurred for: (i) bacteriological tests up to a maximum of EUR 15 on average per test; (ii) the purchase of vaccines up to a maximum of EUR 0,75 on average per dose; (iii) the remuneration of private practitioners performing vaccination and sampling activities under the programme; (iv) the salaries of seasonal staff specially recruited for management of data on the implementation of the measures of that programme; (c) shall be at a rate of 50 % of the eligible costs to be incurred for the compensation to be paid to owners for the value of its animals slaughtered subject to that programme up to a maximum of EUR 50 on average per animal; and (d) shall not exceed EUR 3290000.

1 The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, Germany, Estonia, Greece, Spain, France, Italy, Latvia, Lithuania, Malta, Austria, Poland, Portugal, Romania, Slovenia, Slovakia and Finland are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The financial contribution by the Union: (a) shall be at a rate of 50 % of the unit cost defined in points 1(c) and 4(d) of Annex I for: (i) the sampling of domestic animals; (ii) ELISA tests; (iii) PCR tests; (b) shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines up to a maximum of EUR 0,50 on average per dose; (c) shall not exceed the following: (i) EUR 11000 for Belgium; (ii) EUR 7000 for Bulgaria; (iii) EUR 70000 for Germany; (iv) EUR 3000 for Estonia; (v) EUR 75000 for Greece; (vi) EUR 590000 for Spain; (vii) EUR 170000 for France; (viii) EUR 350000 for Italy; (ix) EUR 15000 for Latvia; (x) EUR 8000 for Lithuania; (xi) EUR 5000 for Malta; (xii) EUR 5000 for Austria; (xiii) EUR 25000 for Poland; (xiv) EUR 125000 for Portugal; (xv) EUR 35000 for Romania; (xvi) EUR 13000 for Slovenia; (xvii) EUR 25000 for Slovakia; (xviii) EUR 5000 for Finland.

1 The annual programmes for the control of certain zoonotic Salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Bulgaria, Denmark, Germany, Estonia, Ireland, Greece, France, Croatia, Italy, Cyprus, Latvia, Luxembourg, Hungary, Malta, the Netherlands, Austria, Portugal, Romania, Slovenia, Slovakia and the United Kingdom are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The annual programme for the control of certain zoonotic Salmonella in flocks of turkeys (Meleagris gallopavo) submitted by Poland is hereby approved for the period from 1 January 2014 to 31 December 2014.

3 The annual programme for the control of certain zoonotic Salmonella in breeding flocks of Gallus gallus submitted by the Czech Republic is hereby approved for the period from 1 January 2014 to 31 December 2014.

4 The multiannual programmes for the control of certain zoonotic Salmonella in laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by the Czech Republic are hereby approved for the period from 1 January 2014 to 31 December 2016.

5 The multiannual programme for the control of certain zoonotic Salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by the Spain is hereby approved for the period from 1 January 2014 to 31 December 2016.

6 The multiannual programme for the control of certain zoonotic Salmonella in breeding, laying and broiler flocks of Gallus gallus submitted by Poland is hereby approved for the period from 1 January 2014 to 31 December 2016.

7 The multiannual programme for the control of certain zoonotic Salmonella in breeding and laying flocks of Gallus gallus submitted by Belgium is hereby approved for the period from 1 January 2014 to 31 December 2019.

8 The financial contribution by the Union for the year 2014: (a) shall be at a rate of 50 % of the unit cost defined in points 2 and 4(e) of Annex I for: (i) the sampling of poultry flocks; (ii) bacteriological tests; (iii) serotyping tests; (iv) tests to verify the efficacy of disinfection; (v) tests for the detection of antimicrobials; (b) shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraphs 1 to 7 for: (i) purchase of vaccine up to a maximum of EUR 0,05 on average per dose; (ii) the compensation to be paid to owners for the value of: the culled breeding birds of Gallus gallus up to a maximum of EUR 4 on average per bird, the culled laying birds of Gallus gallus up to a maximum of EUR 2,20 on average per bird, the culled parent breeding turkey birds of Meleagris gallopavo up to a maximum of EUR 12 on average per bird, the destroyed hatching eggs of parent breeding Gallus gallus up to a maximum of EUR 0,20 on average per egg, the destroyed table eggs of Gallus gallus up to a maximum of EUR 0,04 on average per egg, the destroyed hatching eggs of parent breeding Meleagris gallopavo up to a maximum of EUR 0,40 on average per egg; (c) and shall not exceed the following: (i) EUR 1070000 for Belgium; (ii) EUR 50000 for Bulgaria; (iii) EUR 175000 for the programme of the Czech Republic referred to in paragraph 3; (iv) EUR 710000 for the programme of the Czech Republic referred to in paragraph 4; (v) EUR 90000 for Denmark; (vi) EUR 1335000 for Germany; (vii) EUR 20000 for Estonia; (viii) EUR 25000 for Ireland; (ix) EUR 620000 for Greece; (x) EUR 760000 for Spain; (xi) EUR 860000 for France; (xii) EUR 160000 for Croatia; (xiii) EUR 550000 for Italy; (xiv) EUR 95000 for Cyprus; (xv) EUR 240000 for Latvia; (xvi) EUR 10000 for Luxembourg; (xvii) EUR 1940000 for Hungary; (xviii) EUR 30000 for Malta; (xix) EUR 2700000 for the Netherlands; (xx) EUR 1190000 for Austria; (xxi) EUR 20000 for the programme of Poland referred to in paragraph 2; (xxii) EUR 2610000 for the programme of Poland referred to in paragraph 6; (xxiii) EUR 35000 for Portugal; (xxiv) EUR 1170000 for Romania; (xxv) EUR 35000 for Slovenia; (xxvi) EUR 970000 for Slovakia; (xxvii) EUR 40000 for United Kingdom.

1 The programmes for the control and monitoring of Classical swine fever submitted by Bulgaria, Germany, France, Croatia, Latvia, Hungary, Romania and Slovakia are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The financial contribution by the Union: (a) shall be at a rate of 50 % of the unit cost defined in points 1(d) and 4(f) of Annex I for: (i) the sampling of domestic animals; (ii) ELISA tests; (iii) PCR tests; (iv) virological tests; (b) shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for: (i) the delivery of wild boars to the authorities for laboratory testing up to a maximum of EUR 5 on average per animal; (ii) the purchase of oral vaccines up to a maximum of EUR 0,50 on average per dose; (c) shall not exceed the following: (i) EUR 150000 for Bulgaria; (ii) EUR 670000 for Germany; (iii) EUR 15000 for France; (iv) EUR 65000 for Croatia; (v) EUR 295000 for Latvia; (vi) EUR 40000 for Hungary; (vii) EUR 1435000 for Romania; (viii) EUR 345000 for Slovakia.

3 Notwithstanding paragraph 2 points (a) and (b), for the part of the Latvian programme that will be implemented in Belarus, the financial contribution by the Union for the year 2014 shall: (a) be granted only for the eligible costs of the purchase of oral vaccine baits up to a maximum of EUR 1 on average per dose; (b) be at the rate of 100 %; and (c) not exceed EUR 135000.

1 The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The financial contribution by the Union: (a) shall be at a rate of 50 % of the unit cost defined in points 1(e) of Annex I for the sampling of domestic animals; (b) shall be at a rate of 50 % of the eligible costs to be incurred by Italy for: (i) ELISA tests up to a maximum of EUR 1 on average per test; (ii) PCR tests up to a maximum of EUR 5 on average per test; (iii) virological tests up to a maximum of EUR 10 on average per test; (c) shall not exceed EUR 790000 for Italy.

1 The annual surveillance programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Croatia, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, Austria, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The multiannual surveillance programmes for avian influenza in poultry and wild birds submitted by the Czech Republic and Poland are hereby approved for the period from 1 January 2014 to 31 December 2016.

3 The multiannual surveillance programme for avian influenza in poultry and wild birds submitted by the Netherlands is hereby approved for the period from 1 January 2014 to 31 December 2017.

4 The financial contribution by the Union for the year 2014: (a) shall be at a rate of 50 % of the unit cost defined in points 1(f) and 4(g) of Annex I for: (i) the sampling of domestic birds; (ii) ELISA tests; (iii) agar gel immune diffusion tests; (iv) HI test for H5/H7; (v) virus isolation tests; (vi) PCR tests; (b) shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraphs 1 to 3 for the delivery of wild birds to the authorities for laboratory testing in the framework of passive surveillance up to a maximum of EUR 5 on average per bird; (c) shall not exceed the following: (i) EUR 50000 for Belgium; (ii) EUR 25000 for Bulgaria; (iii) EUR 20000 for Czech Republic; (iv) EUR 50000 for Denmark; (v) EUR 55000 for Germany; (vi) EUR 5000 for Estonia; (vii) EUR 70000 for Ireland; (viii) EUR 15000 for Greece; (ix) EUR 65000 for Spain; (x) EUR 120000 for France; (xi) EUR 75000 for Croatia; (xii) EUR 905000 for Italy; (xiii) EUR 20000 for Cyprus; (xiv) EUR 20000 for Latvia; (xv) EUR 10000 for Lithuania; (xvi) EUR 10000 for Luxembourg; (xvii) EUR 160000 for Hungary; (xviii) EUR 5000 for Malta; (xix) EUR 160000 for the Netherlands; (xx) EUR 25000 for Austria; (xxi) EUR 95000 for Poland; (xxii) EUR 25000 for Portugal; (xxiii) EUR 260000 for Romania; (xxiv) EUR 45000 for Slovenia; (xxv) EUR 25000 for Slovakia; (xxvi) EUR 40000 for Finland; (xxvii) EUR 30000 for Sweden; (xxviii) EUR 135000 for the United Kingdom.

1 The programmes for the monitoring and eradication of certain transmissible spongiform encephalopathies (TSE), submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Spain, France, Croatia, Italy, Cyprus, Latvia, Lithuania, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The multiannual programmes for the monitoring and eradication of certain transmissible spongiform encephalopathies, submitted by Greece and Luxembourg are hereby approved for the period from 1 January 2014 to 31 December 2015.

3 The multiannual programme for the monitoring and eradication of certain transmissible spongiform encephalopathies, submitted by the United Kingdom is hereby approved for the period from 1 January 2014 to 31 December 2018.

4 The financial contribution by the Union: (a) shall be at a rate of 100 % of the unit cost defined in point 4(h) of Annex I for: (i) rapid tests on bovine animals, performed to fulfil the requirements of Article 12 paragraph 2 and Annex III Chapter A Part I points 2.1 and 3 to Regulation (EC) No 999/2001; (ii) rapid tests on bovine animals performed to fulfil the requirements of Annex III Chapter A Part I points 2.2 to Regulation (EC) No 999/2001, under the programmes of Bulgaria, Croatia and Romania or under the programmes of other Member States referred to in paragraphs 1 to 3 on bovine animals originating from Member States not included in the Annex to Commission Decision 2009/719/EC or third countries; (iii) rapid tests on ovine and caprine animals: in accordance with the requirements of Article 12 paragraph 2, Annex III Chapter A Part II point 5 and Annex VII to Regulation (EC) No 999/2001, up to the number necessary to fulfil the minimum requirements of Annex III Chapter A Part II points 2 and 3; (iv) primary molecular discriminatory tests to perform as referred to in point 3(2)(c)(i) of Chapter C of Annex X to Regulation (EC) No 999/2001; (b) shall be at a rate of 75 % of the unit cost defined in point 4(h) of Annex I for rapid tests on bovine animals, performed to fulfil the requirements of Annex III Chapter A Part I point 2.2 to Regulation (EC) No 999/2001, not falling under paragraph (a)(ii); (c) shall be at a rate of 100 % of the eligible costs to be incurred by each Member State referred to paragraphs 1 to 3 for: (i) confirmatory tests, other than rapid tests, as referred to in Annex X Chapter C to Regulation (EC) No 999/2001 up to a maximum of EUR 50 on average per test; (ii) genotyping tests up to a maximum of EUR 6 on average per test; (d) shall be at a rate of 50 % of the cost incurred by each Member State for the compensation of the owners of animals: bovines culled and destroyed up to a maximum of EUR 500 on average per animal, sheep and goats culled and destroyed up to a maximum of EUR 70 on average per animal, sheep and goats compulsorily slaughtered in accordance with Annex VII, Chapter B, point 2.2.2(b) and (c) to Regulation (EC) No 999/2001 up to a maximum of EUR 50 on average per animal; and (e) shall not exceed the following: (i) EUR 260000 for Belgium; (ii) EUR 310000 for Bulgaria; (iii) EUR 250000 for the Czech Republic; (iv) EUR 235000 for Denmark; (v) EUR 2390000 for Germany; (vi) EUR 45000 for Estonia; (vii) EUR 660000 for Ireland; (viii) EUR 1355000 for Greece; (ix) EUR 1525000 for Spain; (x) EUR 7615000 for France; (xi) EUR 2115000 for Italy; (xii) EUR 355000 for Croatia; (xiii) EUR 1060000 for Cyprus; (xiv) EUR 65000 for Latvia; (xv) EUR 55000 for Lithuania; (xvi) EUR 30000 for Luxembourg; (xvii) EUR 660000 for Hungary; (xviii) EUR 15000 for Malta; (xix) EUR 435000 for the Netherlands; (xx) EUR 345000 for Austria; (xxi) EUR 1220000 for Poland; (xxii) EUR 475000 for Portugal; (xxiii) EUR 1675000 for Romania; (xxiv) EUR 115000 for Slovenia; (xxv) EUR 170000 for Slovakia; (xxvi) EUR 100000 for Finland; (xxvii) EUR 105000 for Sweden; (xxviii) EUR 1475000 for the United Kingdom.

1 The annual programmes for the eradication of rabies submitted by Bulgaria, Estonia, Italy, Lithuania, Hungary, Poland, Romania and Slovakia are hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The multiannual programme for the eradication of rabies submitted by Greece is hereby approved for the period from 1 January 2014 to 31 December 2015.

3 The multiannual programmes for the eradication of rabies submitted by Latvia and Finland are hereby approved for the period from 1 January 2014 to 31 December 2016.

4 The multiannual programme for the eradication of rabies submitted by Croatia is hereby approved for the period from 1 January 2014 to 31 December 2018.

5 The multiannual programme for the eradication of rabies submitted by Slovenia is hereby approved for the period from 1 January 2014 to 31 December 2019.

6 The financial contribution by the Union for the year 2014: (a) shall be at a rate of 75 % of the unit cost defined in point 4(i) of Annex I for: (i) fluorescent antibody tests (FAT); (ii) serological tests; (b) shall be at a rate of 75 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for: (i) the delivery of wild animals to the authorities for laboratory testing up to a maximum of EUR 10 on average per animal; (ii) tests for the detection of biomarker up to a maximum of EUR 7,50 on average per test; (iii) the isolation and characterisation of rabies virus up to a maximum of EUR 30 on average per investigation; (iv) the titration of the virus contained a sample of vaccine baits up to a maximum of EUR 75 on average per sample of vaccine baits tested; (v) the purchase of oral vaccine baits up to a maximum of EUR 0,60 on average per bait; (vi) the distribution of oral vaccine baits up to a maximum of 0,35 on average per bait; (c) shall not exceed the following: (i) EUR 1790000 for Bulgaria; (ii) EUR 3210000 for Greece; (iii) EUR 510000 for Estonia; (iv) EUR 165000 for Italy; (v) EUR 1700000 for Croatia; (vi) EUR 1225000 for Latvia; (vii) EUR 2600000 for Lithuania; (viii) EUR 1970000 for Hungary; (ix) EUR 7470000 for Poland; (x) EUR 5500000 for Romania; (xi) EUR 800000 for Slovenia; (xii) EUR 285000 for Slovakia; (xiii) EUR 250000 for Finland.

7 Notwithstanding paragraphs 6 (a) and (b), for the part of the Estonian, Latvian, Lithuanian, Polish and Finnish programmes that will be implemented outside these Member States’ territories, the financial contribution by the Union for the year 2014 shall: (a) be granted only for the eligible costs of the purchase and of the distribution of oral vaccine baits; (b) be at the rate of 100 %; and (c) not exceed: (i) EUR 110000 for the part of the Estonian programme implemented in the Russian Federation; (ii) EUR 475000 for the part of the Latvian programme implemented in Belarus; (iii) EUR 1570000 for the part of the Lithuanian programme implemented in Belarus; (iv) EUR 1500000 for the part of the Polish programme implemented in Ukraine; (v) EUR 660000 for the part of the Polish programme implemented in Belarus; (vi) EUR 95000 for the part of the Finnish programme implemented in the Russian Federation.

8 The maximum of the eligible costs to be reimbursed for the costs referred to in paragraph 7 shall on average not exceed for the purchase and the distribution of oral vaccine baits EUR 0,95 on average per dose.

9 Notwithstanding the provisions of Article 13(2) for the programmes referred to under the current article: (a) the Commission, upon the request of the concerned Member State, may pay an advance of up to 60 % of the specified maximum amount within the 3 months following the receipt of the request; (b) eligible costs referred to in paragraph 7 shall be eligible if paid by the authorities of the third country in the territory of which the activities have been implemented and a final report and payment request has been submitted to the concerned Member State.

1 A financial contribution to Italy for the implementation of reinforced control measures in ports and airports of Sardinia for the prevention of the spread of African swine fever is hereby approved for the period from 1 January 2014 to 31 December 2014.

2 The financial contribution by the Union: (a) shall be at a rate of 50 % of the eligible costs to be incurred by Italy for the implementation of the measures referred to in paragraph 1; (b) shall not exceed EUR 50000.

1 The financial contribution by the Union provided for in Articles 2 to 11, shall be the proportion specified in those Articles of: (a) the unit costs as set for each programme in Annex I; (b) eligible costs limited to the costs set out in Annex II.

2 Only costs incurred in the carrying out of the annual or multiannual programmes referred to in Articles 2 to 12 and paid before the submission of the final report by the Member States shall be eligible for co-financing by means of a financial contribution by the Union.

1 The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax and all other taxes.

2 Where the expenditure of a Member State is in a currency other than the euro, the Member State concerned shall convert it into euro by applying the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State.

1 The financial contribution by the Union for the annual and multiannual programmes referred to in Articles 2 to 12 shall be granted provided that the Member States concerned: (a) implement the activities and measures as described in the programmes approved; (b) implement the programmes in accordance with the relevant provisions of Union law, including rules on the marketing authorisation of veterinary medicinal products and rules on competition and on the award of public contracts; (c) bring into force by 1 January 2014 at the latest the laws, regulations and administrative provisions necessary for actually fully implementing the programmes as of the 1 January 2014; (d) forward to the Commission, the intermediate technical and financial reports for the programmes, in accordance with Article 27(7)(a) of Decision 2009/470/EC and Article 3 of Commission Decision 2008/940/EC ; (e) forward an annual detailed report to the Commission for the programmes in accordance with Article 27(7)(b) of Decision 2009/470/EC and Article 4 of Decision 2008/940/EC; (f) do not submit further requests for other contributions from the Union for those measures, and have not previously submitted such requests.

2 Where a Member State does not comply with paragraph 1, the Commission may reduce the financial contribution by the Union having regard to the nature and gravity of the infringement, and to the financial loss for the Union.

This Decision constitutes a financing decision in the meaning of Article 84 of the Financial Regulation.

This financing decision is subject to the availability of the appropriations provided for in the draft budget for 2014 after the adoption of the budget for 2014 by the budgetary authority or if the budget is not adopted as provided for in the system of provisional twelfths.

This Decision shall apply from 1 January 2014.

This Decision is addressed to the Member States.